Particularly, patients #14 and #24 carry the JAK2 c.1849G > T; p.Val617Phe variant, associated with polycythaemia vera, essential thrombocythaemia and primary myelofibrosis [41, 42]. This evidence concerns the gene JAK2 and essential thrombocythemia.